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Introduction

Abstract

Loftus
and Albrecht
( 17, 18) used fibrinogen
labelled colloidal gold (Fgn-Au) in conjunction
with
platelet whole mount preparations to directly visualize
the fibrinogen receptor.
These studies have shown that
platelet
shape change is accompanied
by fibrinogen
receptor redistribution
and point to a direct correlation
between
fibrinogen
receptor
redistribution
and the
development
of cytoskeletal
dependent ultrastructural
zones; thus suggesting
a link between the surface
receptors and the cytoskeleton.
The GPIIb-Ill has been
identified
as the platelet
membrane
glycoprotein
complex to which fibrinogen binds (20,23). There have
been various other studies
that also suggest this
membrane receptor to be associated with the platelet
cytoskeleton (22,23).
Actin is the most abundant cytoskeletal protein in
platelets,
accounting for 15-20% of the total platelet
protein (2).
The interaction
of actin with myosin
requires the f.hosphorylation
of the 20k myosin light
chain by Ca + - calmodulin dependent myosin light
chain kinase (MLCK) (11).
Several studies
have
indicated
that contractile
activity
in platelets
is a
function of the state of myosin phosphorylation, and the
extent of myosin phosphorylation
is, in turn, a product
of the relative
activities
of myosin kinase and
phosphatases (1,16).
Much attention
has been focused on the platelet
cytoskeleton
as a determinant
of platelet shape change,
granule secretion,
and clot retraction
(3,4, 17). The
present study makes use of correlative VDlC microscopy
and colloidal gold labeling in conjunction with high
voltage and scanning electron microscopy to examine
the involvement
of myosin phosphorylation
in the
fibrinogen receptor
redistribution
that occurs during
platelet shape change.

Video-enhanced
differential
interference
contrast
(VDIC) light microscopy in conjunction with fibrinogen
labelled colloidal gold was employed as a probe to
follow the mobility of the fibrinogen receptor
on
platelets.
Correlative
studies by both high voltage and
scanning electron
microscopy confirms localization of
labels relative
to platelet ultrastructural
and surface
characteristics,
respectively.
Treatment
of platelets
with trifluoperazine
prior to and after incubation with
fibrinogen-gold
labels
results
in a concentration
dependent inhibition of receptor movement. The results
obtained from this study suggest that phosphorylation of
myosin by the Ca++ - calmodulin dependent enzyme,
myosin-light chain kinase, is important in the fibrinogen
redistribution
that occurs during platelet activation.
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myosin
phosphorylation,
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Materials

and Methods

Preparation of colloidal gold
A stock solution of colloidal gold granules having
an average diameter of 18 nm was prepared by reducing
HAuC1 4 with trisodium
citrate
(8,9,10,12).
A 4%
solution of HAuC1 4 (0.5 ml) was added to 200 mis of
deionized distilled water and brought to a boil.
A
freshly prepared solution of 1% trisodium citrate (5 ml)
was rapidly added to the boiling solution and the
mixture refluxed for 30 minutes. The formation of the
monodisperse colloidal particles was indicated by a dark
blue to red color change.
The colloidal solution was
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gain.
A Colorado Video processor is used for further
image enhancement.
Micrographs
are recorded
on
Kodak plus-x-film
either in real time or from video
tape.
Video enhancement
increases
contrast
and
visibility (15).
Formvar-coated
grids were placed on # 1-1/2
coverslips and affixed with strips of double-sided tape
overlying
the grid edges.
Glass strips cut from
coverslips were placed on two sides of the grid as shims
to determine
the cell thickness.
A single coverslip
(18X 18 mm, # 1) was then placed on top of the shims and
sealed in place with melted Valap, a 1:1:1 mixture of
vasol ine,
lanai in, and paraffin.
The resultant
preparation
was open at two ends to enable introduction
and exchange of media by capillary filling. Gold labels
and/or
pharmacologically
active agents were added
while the platelets were being observed.
In the present
study,
platelets
were
treated
with
the various
concentrations
of trifluoperazine
for 5 mins prior to and
after incubation with Fgn-Au. Platelets were incubated
with forskolin for 10 mins, followed by the addition of
Fgn-Au labels. Similarly, glutaraldehyde
may be added
for an initial fixation of the platelets.
At the end of
each experiment,
the Valap seal was broken, specimens
were removed
without
drying, and processed
for
electron microscopy.
Electron Microscopy
Samples were fixed in 0.1 M Hepes buffered 1 %
glutaraldehyde,
0.2% tannic acid, 0.05% saponin pH 7.2
for 30 minutes at room temperature.
All preparations
were post fixed in 0.1 M Hepes-buffered
0.05% OsO 4 for
15 mins, and stained in 1% uranyl acetate (aqueous), for
15 mins. The specimens were then dehydrated through a
graded series of alcohol to absolute ethanol, itself dried
by storage over molecular sieve. Samples were dried by
the critical
point procedure
in a critical point dryer
equipped with an in-line molecular sieve filter and a
hydrophobic water-excluding
filter (24). CO 2 was used
as the transitional
fluid.
Samples were evaporatively
coated with a thin layer of carbon and stored over
molecular
sieve at 0% relative
humidity
- until
examined with the AEl EM7 1 MeV electron microscope
of the Madison HVEM facility.
Stereo-pair micrographs
were taken at tilt angles appropriate
for specimen
thickness and magnification (13). Samples were sputter
coated with gold-palladium
and examined using a JEOL
JSM 35 scanning
electron
microscope
at 10-20kV
accelerating
voltage.

cooled, filtered through a microporous filter (Millipore
Millex - GS 0.22 µm filter unit), and stored at 4°c under
sterile conditions.
Preparation of fibrinogen and fibrinogen-gold complex
Fibrinogen (Fgn) was purified from fresh frozen
human citrated
plasma by precipitation
with 25%
saturated
ammonium
sulfate
followed
by DEAE
cellulose chromatography
(19). The final product was
dissolved in and dialyzed against 0.01 M Tris and 0.14 M
NaCl buffer pH 7.4. Aliquots of 1 mg/ml were frozen in
alcohol-dry ice and stored at -7o 0 c.
Adsorption
isotherms
were
performed
to
determine the minimum amount of fibrinogen necessary
to stabilize the colloidal gold. The gold solution was
adjusted to pH 6.5 with 0.2 N K 2 co 3 as measured by
gel-filled
combination
electrode
(No. 9115, Orion
Research Inc., Cambridge, MA). A series of fibrinogen
solutions of increasing concentration
were made up to 1
ml and added to 5 mis of colloidal gold. After 1 minute
at room temperature,
1 ml of 10% NaCl solution was
added to the fibrinogen-gold.
Inadequate stabilization
of the colloid results in flocculation of the gold granules
indicated by a color change from red to blue.
The
minimum amount of fibrinogen necessary to prevent
flocculation was• 8 µg/mg of gold solution.
Ten mis of gold solution (pH 6.5) was added to a
10% excess of dialyzed fibrinogen (0.005 M NaCl) and
mixed by gentle inversion.
After 5 minutes at room
temperature,
0.5 ml of freshly prepared and prefiltered
(Millipore 0.45µm} polyethylene glycol (MW 20,000) was
added to further
stabilize
the colloidal gold.
The
fibrinogen labelled gold was concentrated
and excess
fibrinogen removed by centrifugation
in polycarbonate
tubes at 11,000xg for 30 minutes at 4°C.
The
supernatant
was discarded,
and the concentrated
red
pool was resuspended
to 1 ml with sterile filtered
(Millipore
0.2
µm} protein-free
tyrodes
buffer
supplemented with 1 mM Ca++.
Platelet Preparation
Platelets were obtained from normal healthy adult
volunteers by venous puncture.
Blood samples (10 ml)
were collected in polypropylene tubes containing 10 mM
EGTA and mixed by gentle inversion.
Platelet-rich
plasma was prepared by centrifugation
of whole blood at
180 x g for 10 mins.
Platelets
were separated from
plasma proteins by passage through a Sepharose CL-4B
column (26) having a 40 ml bed-volume.
The column
was equilibrated
at room temperature
with a calciumfree tyrodes buffer, pH 7.3 (136 mM NaCl, 2.7 mM KC!,
0.42 mM NaH 2 PO 4 , 12 mM NaHCO , 2 mM MgClz6H 2 O,
3
1 g/L dextrose,
and 2 g/1 albumm).
Platelets
were
collected in the void volume, into polypropylene tubes
for the experiments.
Video Microscopy
Observations
of live platelets
were performed
using
a video-enhanced
differential
interference
contrast
(VDIC) light microscope
having condenser
rectification.
This is an inverted microscope, designed
to observe cell attachment.
This microscope is built on
a Nikon diaphot base modifed for both high illumination
intensity and low light loss, necessary when working at
the
high extinction
ratio
required
for ultimate
resolution
with polarization
optics (14).
For high
resolution work using the 1.25 NA l00X objective, the
final screen magnification
of approximately
6000X is
made available by changing the TV camera projector
lens. A Dage MTl Newvicon video camera is used for
its high sensitivity and excellent linearity (0.5%) and is
modified for manual adjustment
of black levels and

Results
Figure 1 shows a surface activated,
fully spread
platelet that was incubated with Fgn-Au labels. These
series of VDIC light micrographs depict the progressive
centralization
of the Fgn-Au labels. The final surface
distribution
of
labels
on light
micrograph
1D
corresponds
to the inner filamentous zone as seen by
HVEM (17,18) and as seen in Fig. 2. Figure 2 shows the
high voltage electron micrograph (HVEM) of the platelet
in Figs. lA-D. The structure of the cytoskeleton can be
seen to be divided into four distinct zones : the
peripheral web composed of a densely packed meshwork
of fine filaments,
interior
to this is the outer
filamentous zone with its more loosely interwoven array
of filaments,
and finally an inner filamentous
zone of
densely
packed
overlapping
network
of filaments
surrounds the granulomere
region. The localization of
the labels over the inner filamentous zone as seen by
light microscopy
is confirmed
by the high voltage
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Figures lA, B, C and D are a series of VDIC light micrographs of a fully spread platelet treated with Fgn-Au labels
for 5 minutes.
(A) shows the platelet just after addition of Fgn-Au labels.
The peripheral web (arrows) is
unattached
to the substratum and can be seen as a dark band due to ruffle induced optical interference.
The dark
regular round spots (g) are platelet granules.
The Fgn-Au labels are diffuse at this stage, reflecting
the general
distribution of the,GPilb-lII complexes.
Some clusters of labels dense enough to be detected appear on the platelet
as light gray irregular or oval bands or areas (arrowheads).
(B) shows the same platelet 2 minutes after incubation
with Fgn-Au labels. The more regular black spots on the platelet represent the granules while the irregular bands,
oval clusters and more irregular spots are indicative of varying densities of Fgn-Au labels (arrowheads).
(C) is the
same platelet taken 3 minutes after addition of Fgn-Au labels. Note the increased density of the irregular dark
bands and spots due to the large number of Fgn-Au labels clustering on the platelet membrane over the inner
filamentous
zone (arrowheads).
(D) shows the platelet 5 minutes after incubation with the labels. The peripheral
regions are cleared of labels, which are now nearly fully centralized
and clearly visible as a dark irregular band
(arrowheads) surrounding the granulomere region. Picture width= 10.5 µm.
this agent resulted in a decentralization
of the Fgn-Au
labels, and an elongation of the pseudopodia.
The high
voltage electron
micrograph of this same platelet
is
depicted in Figure 5. The four distinct ultrastructural
zones, characteristic
of spread platelets are no longer
evident in this trifl uoperaz ine-treated
platelet.
The
Fgn-Au labels have become decentralized
and some
labels have relocated to the elongated pseudopodia and
over the cytoplasmic
processes that have developed.
The scanning
electron
micrograph
of this platelet,
demonstrating
the surface localization of the labels, is
shown in Figure 6.
We have also observed
that

electron
microscopy.
Figure 3 is a scanning electron
micrograph
of this same platelet.
This shows the
localization
of the Fgn-Au labels on the surface of the
platelet
membrane and on some, but not all, of the
granules or granule membranes
which appear on the
surface of the platelet
during the shape change and
associated granule release sequence.
Figures
4A-C
are a series
of VDIC light
micrographs showing the redistribution
of Fgn-Au labels
in the spread platelet.
Following the centralization
of
labels,
the
platelet
was treated
with
50 µM
trifluoperazine.
As shown in Figure 40, treatment with
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Figure 2.
HVEM stereo
pair whole mount of the
. ~OFZ
same platelet seen in Figs.
lA-D. This shows the four
distinct
ultrastructural
zones: the peripheral
web
(PW), the outer filamentous
zone
(OFZ),
the
inner
'·ii;
filamentous zone (!FZ), and
the granulomere
(G). Note
the
location
and
high
!(,
density
of labels
which
,¥
appear
as
small
black
spheres
over
the
inner
·:·•,(~: . .
filamentous
zone.
Labels
under the peripheral
web
are trapped under the free
edge
(nonsubstrate
attached)
of the platelet
and do not indicate specific
binding.
Several
very
dense areas
of labelling
(arrows) can be seen. These appear to correlate with the surface presence (see Fig. 3) of granules or membrane
from degranulated
granules which may contain concentrations
of the GPIIb/III complex.
Certain of these
externalized
granules show minimal or no labelling (stars), also see the same granules in Figure 3. Bar = 1 µm.

'

..

~'.~:<
;~::,
..

·-

prior to and after incubation with Fgn-Au labels. These
concentrations
of trifluoperazine
did not inhibit, nor
reverse,
redistribution
of Fgn-Au labels.
A similar
trend of inhibition of receptor movement observed by
VDIC light microscopy and confirmed by high voltage
and scanning electron
microscopy was obtained with
forskolin.
While treatment of platelets with 100 µMand
50 µM forskolin prevented
or significantly
inhibited
fibrinogen receptor redistribution,
lower concentrations
(5, 10, 20 µM} did not exert any inhibitory effect on Fgnreceptor redistribution.
Discussion
Studies at the light microscopic level employing
immunocytochemical
techniques
have revealed
that
there
are
temporal
changes
in the
whole cell
distribution
of actin and myosin within the spreading
platelet
(5,21).
While actin and myosin initially are
uniformly
distributed
within the platelet,
they are
segregated
into
selective
areas
as
spreading
progresses.
Loftus
et
al.
(17, 18) have
also
demonstrated
actin bundles in the pseudopods, while in
the fully spread platelets,
actin filaments are seen in
the outer filamentous
zone and in somewhat higher
density
in the peripheral
web and in the inner
filamentous
zone which surrounds the granulomere.
There are also data to suggest that the platelet
fibrinogen receptor (GPllb-III complex) is linked to the
cytoskeletal
elements (22,23). This segregation of the
cytoskeletal
proteins during platelet
spreading could
provide
the mechanism
for force generation
and
discrete inward movement of the receptor.
In
cells,
the
biochemical
equivalence
of
contractile
activity is measured in terms of myosin's
ability to hydrolyze Mg-ATP.
In smooth muscles az~
vertebrate
non-muscle cells such as the platelets, Ca
regulates
the actin-activated
Mg-ATPase activity of
myosin by activating
the enzyme myosin light chain
kinase (MLCK). The effect of Ca++ is mediated through
the ca++ binding protein calmodulin,
which is very
similar to a number of Ca++ binding proteins in that it
contains four divalent cation binding sites. Inhibition of

Figure 3. The same platelet as in Figures 1 and 2.
Scanning electron micrograph clearly demonstrating the
pattern of surface localization
of the Fgn-Au labels
which appear as tiny light gray spheres.
Labels are
absent
from the peripheral
areas of the platelet
membrane i.e. those areas which overlie the peripheral
web and the outer filamentous
zone.
Larger light
spherical
to irregular
surface
bodies (arrows) are
thought to be granules or granule membranes which
appear on the platelet surface during degranulation and
granule
exocytosis.
Some of these
externalized
membranes show little labelling (stars) while others are
heavily labelled (see Fig. 2.). This micrograph is rotated
40° counterclockwise
relative to the HVEM micrograph
(Fig. 2.) Bar = 1 µm.

pretreatment
with 50 µM trifluoperazine
prevents the
initial
redistribution
of labels in the fully spread
platelet (results not shown). Platelets were also treated
with lower concentrations
(5, 10, 20 µM) trifluoperazine
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Figures 4A, B, C, and D show the VDIC micrographs of a spread platelet.
(A) depicts the platelet prior to
incubation with Fgn-Au labels. The peripheral web is seen here as a dark band (arrows). The dark regular spots in
the platelet are granules in the granulomere region (g). (B) shows the light micrograph of the same platelet 2
minutes after the addition of Fgn-Au. Note the diffuse distribution of labels over the entire platelet membrane.
Areas where labels are concentrated
can be seen as medium to dark gray irregular patches, bands and spots
(arrowheads).
Several dark spots beyond the edge of the platelet (X) are granules or granule membranes which have
come off the platelet during the surface activation and attached to the adjacent substrate.
(C) shows the same
platelet
5 minutes after incubation with Fgn-Au labels.
The labels are prominent as a dark irregular band
surrounding the granulomere (arrowheads).
Note also the clearing of labels from the peripheral area of the platelet
and labelled granule membranes (X) which have come off the platelet.
(D) shows the same platelet 4 minutes after
treatment
with 50 µM trifluoperazine.
The Fgn-Au labels (arrowheads) have become decentralized
and are now
dispersed individually and in clumps of varying density over the entire platelet membrane.
Platelet granules can
still be found in the granulomere region. Note also that the pseudopodia (enclosed stars) have become elongated,
prominent and are labelled. The peripheral web (arrows) also appears irregular, consistent with the development of
small pseudopodia
at the platelet
margin.
This appearance
is typical of platelets
treated
with 50 µ M
trifluoperazine.
Picture width= 10.1 µm.

this
enzyme
with
calmodulin
antagonists
prevent
phosphorylation
of myosin and blocks its interaction
with actin.
As shown by our results, inhibition of
myosin phosphorylation
with 50 µM trifluoperazine
reverses the redistribution
of Fgn-Au labels.
We have
also
found
that
pretreatment
of platelets
with
trifluoperazine
prior to Fgn-Au labelling
prevents
receptor redistribution
(data not shown).

In our studies,
we observed
a concentration
dependent
inhibition of receptor
redistribution.
This
correlates
with previous findings of Fox and Phillips (7)
in which they showed that preincubation
of platelets
with trifluoperazine
caused a concentration
dependent
inhibition
of thrombin-induced
phosphorylation
of
myosin light chain and incorporation of myosin into the
platelet
cytoskeleton.
The maximum inhibition was
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Figure 5.
HVEM stereo
pair, whole mount of the
platelet seen in Figs. 4A-D,
treated
with
50
µM
trifl uoperaz ine
for
5
minutes
after
incubation
•
with Fgn-Au labels for 5
minutes.
Note
the
dispersed
distribution
of
labels individually
and in
•
small
patches
over
the
entire platelet
membrane,
including
the
extended
pseudopodia
(arrowheads).
Bundles of actin filaments
can be seen extending into
the large, and many of the
small,
pseudopodia
(arrows).
Note also the
many
cytoplasmic
processes,
and
small
pseudopodia,
(a) at the
margin of the platelet extending from the former position of the peripheral web. Fgn-Au-receptor
complexes are
apparent individually and in small clusters, on the large and small pseudopodia.
The four distinct ultrastructural
zones consistent with cytoskeletal
reorganization
in the spread platelet are no longer present. Also of interest are
granules or granule membranes which left the platelet prior to trifluoperazine
treatment.
Several of these are
heavily labelled (X) and others (0) are not. Bar= 1 µm.
obtained with 50 µM trifluoperazine.
The results we
obtained with forskolin, an adenylate cyclase stimulant
also lend support to the role of myosin phosphorylation
and
the
cytoskeletal
proteins
in
Fgn-receptor
redistribution.
Our findings suggest that the modulator protein,
calmodulin,
plays an important
role in fibrinogen
receptor
redistribution
through
a Ca++ -dependent
phosphorylation
of myosin light chain kinase. However,
these
results
do not exclude
the possibility
that
trifluoperazine
could also be affecting enzyme systems
or proteins
other than myosin light chain kinase.
Sanchez et al (25) have reported that trifluoperazine
inhibited
platelet
secretion
evoked by activators
of
protein kinase C. However, the concentrations
required
were considerably
lower than those which we have
shown are necessary to block the fibrinogen receptor
redistribution.
The use of VDIC microscopy
and
colloidal gold labelling in conjunction with high voltage
and scanning
electron
microscopy
is effective
in
following receptor
movement on living cells.
This is
also useful in determining the effects of pharmacologic
agents
on receptor
distribution
and cytoskeletal
structure.
It is also of interest to point out that platelet
granule or granule membranes appear on the surface of
platelets as a consequence of normal surface activation
and granule release.
Certain of these can be seen by
VDIC to fall off the platelet during normal activation.
Subsequent labelling indicates some of these granules to
label strongly
with Fgn-Au whether on or off the
platelet while others are unlabelled.
This would tend to
support
previous findings demonstrating
GP!lb-Jll in
some, but not all, platelet granule membranes (6).

Figure 6 shows the scanning electron micrograph of the
same platelet
as in Figs. 4 and 5; treated with 50 µM
trifluoperazine
after incubation with Fgn-Au labels for
5 minutes.
Note the decentralization
of the Fgn-Au
labels (arrowheads) and their surface localization on the
body of the platelet as well as on pseudopodia and small
cell processes.
Granules and granule membranes can be
observed on the platelet surface as larger light colored
spherical bodies. Some have come off the platelet and
can be seen attached to the surrounding substrate.
The
VDIC micrographs
(Figures 4A-D) demonstrate
that
many of these left the platelet
as a consequence of
normal activation
prior to trifluoperazine
treatment.
From Fig. 5 (the HVEM of these same granules), some of
these
granules
or granule
membranes
label with
fibrinogen gold (X) while others (0) do not. Bar = 1 µm.
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Discussion

with Reviewers

D. Handley:
The methods of platelet activation
using
formvar grids has been published, so also the Fgn-gold
labeling method.
Do you not think that much of the
data is duplicative of pre-existing
work?
Authors:
The emphasis of the paper is to present the
techniques relative to colloidal gold labeling.
We have
attempted
to show the effective
combination of VDIC,
SEM, and HVEM in conjugation
with colloidal gold
labeling.
We specifically
wished to demonstrate
that
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0. Handley:
How many times were these experiments
run?
Where in the methods did you state how the
trifluoperazine
and forskolin experiments were done?
Authors: Experiments with trifluoperazine
and forskolin
have been done at least three times and in each case
there were controls (i.e., platelets treated with Fgn-Au
only).
The methods
section
describes
how the
experiments were carried out.

the actual
movement
of the colloidal gold labeled
receptors, or the inhibition thereof, could be followed in
living platelets by VDIC and subsequently confirmed and
related to cytoskeletal
structure using SEM and HVEM.
This approach is unique and has not been previously
published
nor have the findings regarding
receptor
movement relative to inhibitory agents, thus the title
"Trifluoperazine
Inhibition
of Fibrinogen
Receptor
Redistribution
in
Surface
Activated
Platelets:
Correlative
VDIC, HVEM, and SEM Studies."
The
disposition and labeling of exocytosed platelet granules
is also a novel finding.

0. Handley:
Treatment
with trifluoperazine
(TFP)
caused decentralization
of the Fgn-Au labels (Figure
40) - how much?
Authors:
The extent or degree of decentralization
was
not quantified.
However, the localization of labels prior
to and after the addition of various concentrations
of
TFP to platelets
was monitored
and as has been
described, labels can be observed at the peripheral areas
of the platelet
and on newly forming pseudopods that
were arising from areas which were free of labels prior
to the addition of TFP. In other words, the labels which
were previously located only over the central areas of
the platelet
have
moved,
such that
they were
distributed over the entire cell surface.

D. Handley:
Do cells not labeled with Fgn-Au display
the optically dense areas denoted by arrows in Figures
lA-O?
Authors:
No. The only portions of an unlabeled fully
spread platelet that show such optical density are the
granules and cell edges.
Figure 7 shows two platelets
before and after the addition of Fgn-Au. The optical
density is uniform and low across the unlabeled cells,
except at cell edges, thin pseudopodia, and over the
granules (Fig. 7 A). The same cells 15 minutes after
Fgn-Au addition are shown in Figure 78. The colloidal
gold labels are clearly seen due to the high optical
density of the clustered labels. Label is seen over the
IFZ and granulomere
as well as on the pseudopodia of
the less spread cell.

0. Handley: ls the SEM of Figure 6 really different than
Figure 3?
How do you know that?
What did you
measure? On how many cells?
Authors:
Figure 3 depicts a fully spread platelet
treated
with Fgn-Au labels only.
The labels have
clearly
moved from the peripheral
web and outer
filamentous
zone of the platelet and are present over
the central
area of the platelet.
This pattern
of
distribution
of labels is characteristic
of all the fully
spread control platelets treated with Fgn-Au. Figure 6
on the other hand shows the SEM of a spread platelet
treated with 50 µM TFP following prior incubation of the
platelet with Fgn-Au labels. Treatment with 50 µM TFP
caused,
as shown and indicated
by the arrows, a
decentralization
of the labels resulting in a generalized
distribution
of labels all over the platelet
membrane.
There are also labels on the newly forming pseudopods
at the platelet
margin.
Each experiment
has been
performed at least three times with identical results.

D. Handley: How do you know the Fgn-Au labels reflect
the general distribution of GPllb-111 complexes?
Authors:
Labeling platelets
with monoclonal antibody
directed
against
GPI!b-111 complex
resulted
in an
identical
pattern
of distribution
of the
labels.
Incubation of platelets with soluble fibrinogen followed
by Au-anti Fgn also showed a similar distribution of
labels.
In addition,
pretreatment
of platelets
with
fibrinogen prevented binding of Fgn-Au.
0. Handley:
None of the gold labeling in Figure 2 is in
clusters as large as those shown in Figures lA-O. How
do you explain that?
Could the dense areas in Figures
lA-O be dense granules?
How would you disprove it?
The TEM picture in Figure 5 showed none of the dense
labels seen in Figure 40. Can you explain that?
Reviewer
IV:
There is no obvious correspondence
between the large gray bands in the VDIC and the very
fine particulate
gold in EM. How was it determined
that the Fgn-Au appears as light gray irregular or oval
bands in Figure 1?
Authors:
HVEM and SEM show Fgn-Au clusters in the
same
places
on the platelet
as seen by light
microscopy.
The clusters appear larger because the
18nm colloidal gold labels are an order of magnitude
smaller than the resolution of the light microscope.
Thus the labels can not be resolved but are detected due
to an inflated diffraction
image.
The dense areas in
Figures lA-O are not dense granules because they were
not observed on the platelet prior to the addition of the
labels. Additionally, the correlative HVEM micrographs
prove conclusively
that dense areas are Fgn-Au, not
dense granules, which are also clearly identifiable as to
size and location when viewed by stereo-pair
whole
mount HVEM imaging.
The granules which take up
electron dense stain are often also visible by SEM as
sub-surface
light round or oval areas due to increased
back scattered
electrons
and subsequent
increased
secondary electron emission.

0. Handley:
You stated in the abstract
that TFP
"results
in a concentration-dependent
inhibition
of
receptor movement".
What parameters
of receptor did
you measure? How many cells did you measure it on?
Authors:
The parameter
measured was whether or not
Fgn receptors moved to the central area of the platelet
and hence were cleared from the peripheral areas, i.e.,
absent from the membrane overlying the peripheral web
and outer filamentous
zone.
Incubation of platelets
with 50 µM TFP caused a reversal of Fgn-Au label
centralization
on all (more than 500 fully spread)
platelets examined in four separate experiments.
D. Handley:
When three concentrations
(5, 10, 20 µM)
did not work and one (50 µM) does, how can you say it is
concentration
dependent?
If it is, what is the 1c ?
50
Why does 50 µM inhibit and not 20 µM? Are these
concentrations
of TFP important?
Do they relate to
other TFP-platelet
studies (for example Thromb. Res.
29: 63-74, 1983)?
Reviewer IV: Only one concentration
of TFP (50 µM)
resulted in any effect, how then could the authors claim
that TFP caused a concentration-dependent
inhibition of
receptor
movement?
The Kd of TFP for calmodulin
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binding is 1.5 µM and therefore concentrations
in this
range should be effective
a inhibiting
calmodulin
dependent processes.
At 1 x 10 cells/ml, extrapolation
of the TFP dose-response
curve indicates that 5 µM TFP
would saturate
in vivo calmodulin.
Why then did the
authors
fail
to obtain
any effect
of TFP at
concentrations
of TFP below 50 µM, since this appears
to be a much lower platelet concentration?
Authors:
The effect was concentration
dependent in
that three concentrations
were inactive and one was
active.
Subsequently,
additional concentrations
have
been tested, 30 and 40 µM, both inhibited Fgn-receptor
redistribution.
Also, treatment
of platelets with these
concentrations
of TFP after they have already been
incubated with Fgn-Au caused decentralization
of the
labels.
This data
strengthens
the case
for a
concentration
dependent effect of TFP on Fgn-receptor
redistribution.
We feel it inappropriate
to attempt to
determine the 1c50 or to plot a dose-response curve due
to the "all or none" nature of the response measured.
At this point, we see no apparent direct links between
our results and those presented in Thromb. Res. 29: 6374, 1983, except that in both experiments,
the effects
of TFP on different aspects of platelet physiology were
explored.
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D. Handley:
You stated that "inhibition of myosin
phosphorylation
with 50 µM trifluoperazine
reverses
redistribution
of Fgn-Au labels". How did you measure
myosin phosphorylation?
H.H. Edwards:
How have the experiments proven the
claim that inhibition of myosin phosphorylation reverses
the redistribution
of Fgn-Au labels?
Authors:
We have not studied myosin phosphorylation
directly but previous work (7) has examined the role of
phosphorylation
in mediating the association of myosin
with the cytoskeletal
structures
of human platelets.
These authors employed similar concentrations
of TFP
as was used in our experiments
and observed
an
inhibition of thrombin-induced
myosin phosphorylation
and myosin association
with the cytoskeleton,
with
concentrations
of TFP greater
than 20 µM.
This
suggested to us that myosin phosphorylation
might be
important
in Fgn-receptor
redistribution;
however,
these results do not exclude the possibility that TFP
could also be affecting
enzyme systems or proteins
other than myosin light chain kinase.
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